These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7900097)

  • 1. Effect of platelet activating factor antagonists in different models of thrombosis.
    Seth P; Kumari R; Dikshit M; Srimal RC
    Thromb Res; 1994 Dec; 76(6):503-12. PubMed ID: 7900097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA; Magnusson JE; Wurtman RJ
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PAF antagonists on renal vascular escape and tachyphylaxis in perfused rabbit kidney.
    Ferreira MG; Braquet P; Fonteles MC
    Lipids; 1991 Dec; 26(12):1329-32. PubMed ID: 1819726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG; Barnes PJ; Evans TW
    Clin Sci (Lond); 1989 Oct; 77(4):439-43. PubMed ID: 2805602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists.
    Vásquez-Bravo YL; Russo M; Jancar S
    J Lipid Mediat; 1993 Nov; 8(3):135-44. PubMed ID: 8268459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.
    Hunyadi J; Kenderessy AS; Duda E; Braquet P; Dobozy A
    Mol Immunol; 1993 Apr; 30(6):517-9. PubMed ID: 7683748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
    Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
    Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of platelet-activating factor (PAF-acether) to induce decidualization in mice and failure of antagonists of PAF to inhibit implantation.
    Milligan SR; Finn CA
    J Reprod Fertil; 1990 Jan; 88(1):105-12. PubMed ID: 2313629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties.
    Gilfillan AM; Wiggan GA; Hope WC; Patel BJ; Welton AF
    Eur J Pharmacol; 1990 Feb; 176(3):255-62. PubMed ID: 1691711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis.
    Bourgain RH; Andries R; Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists.
    Mathison R; Davison JS; Befus AD
    Br J Pharmacol; 1992 Jun; 106(2):263-6. PubMed ID: 1393261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF).
    Teixeira CF; Cury Y; Oga S; Jancar S
    Toxicon; 1994 Apr; 32(4):419-26. PubMed ID: 8052996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
    Droy-Lefaix MT; Drouet Y; Braquet P; Géraud G
    Adv Exp Med Biol; 1990; 264():419-22. PubMed ID: 2244522
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma.
    Faden AI; Tzendzalian PA
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R909-14. PubMed ID: 1415805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.